v3.25.4
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash Flows From Operating Activities:    
Net loss $ (5,534,069) $ (6,659,205)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Stock-based compensation expense 3,956,050 1,808,478
Amortization of in-process research and development 573,438
Deferred income tax expense 264,240 264,240
Changes in operating assets and liabilities:    
Accounts receivable, net of allowances (4,049,111)
Inventory (352,649) (6,112,603)
Prepaid expenses (1,831,660)
Accounts payable (2,787,784) 2,162,955
Accrued expenses 425,792 6,228,612
Due to related party 1,980,807 2,307,523
Net Cash (Used In) Provided By Operating Activities (7,354,946)
Cash Flows From Investing Activities    
License payments (4,400,000)
Net Cash Used In Investing Activities (4,400,000)
Cash Flows From Financing Activities    
Net proceeds from issuance of common stock 15,125,489
Net Cash Provided by Financing Activities 15,125,489
Net Change in Cash and Cash Equivalents 3,370,543
Cash and Cash Equivalents – Beginning of Period 3,924,908 112
Cash and Cash Equivalents – End of Period 7,295,451 112
Supplemental Disclosures of Cash Flow Information and Non-cash Transactions:    
Interest Paid $ 14,460